U.S. Markets close in 3 hrs 28 mins

CRISPR Therapeutics AG (CRSP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
130.61+1.03 (+0.79%)
As of 12:32PM EST. Market open.
Sign in to post a message.
  • D
    Dornfield
    9th December joint press conference with Vertex to review CTX001 presented information at ASH (2-5th December). I doubt that they are planning this as a means of explaining away a failure. I imagine this is a means of highlighting yet more long term good news. I would anticipate another bump after ASH (the first time news about clinical trials came out, the bump was spectacular, but then more muted when the more recent follow up data came out some time later. Who knows....
    Bullish
  • J
    Jpow
    This company is going to change the way the world treats outlying illnesses. it has created possibilities people haven’t even caught up to yet. In my opinion, one of the most interesting positions in the market right now. still trading at low volume and is still low key. We have some time to keep buying while we wait for future approvals and once it gets approved it’ll change medicine forever. Has true market disruption potential
    Bullish
  • Y
    Yahoo Finance Insights
    CRISPR Therapeutics reached an all time high at 125.72
  • Y
    Yahoo Finance Insights
    CRISPR Therapeutics reached an all time high at 129.97
  • D
    Danny
    Swiss National Bank grew its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) by 31.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 116,300 shares of the company’s stock after acquiring an additional 28,000 shares during the period. Swiss National Bank owned about 0.16% of CRISPR Therapeutics worth $9,727,000 at the end of the most recent quarter.
  • V
    VirginiaLova
    8 percent of the float was short on 11/15/2020 -- smart buying to cover in front of ASH.

    This stock is owned by the institutions, and, some lucky retail holders. It is in strong hands, committed to see this stock go to a $25B market cap before even contemplating selling.

    $CRSP is the best in the space.
    Bullish
  • A
    American
    This is a beautiful thing to witness after believing in the technology for so long and buying in for first time at 37!
    Bullish
  • x
    x
    I just bought in at $110.... am I too late to the game? Could be a world changing company right? Or it is already.. what is the TAM for CRISPR applications?
    Bullish
  • Z
    ZIM
    CRSP HIT NEW ALL-TIME-HIGH OF
    $128.00 AT MARKET CLOSE
  • A
    Adam
    Said it before and I'll say it again. This is probably the most important company in the world for the future of humanity, and they are at the cutting edge (pun intended) for improving health outcomes for diseases and viruses. If you don't believe me, watch Human Nature. Congrats to longs.
    Bullish
  • A
    Anonymous
    What exactly does this company own?
  • Z
    ZIM
    I AM HEAVY CRSP (EMMANUELLE CHARPENTIER),
    BUT RECENTLY ROLLED OVER SOME PROFIT TO NTLA (JENNIFER DOUDNA),
    BECAUSE THEY RECENTLY BROKE ALL TIME HIGH. POSITIVE FOR INTELLIA.
    Bullish
  • C
    Charles
    The durability and length of effectiveness of treatment (for solid tumors and hemoglobinopathies) will make CRSP rise and stabilize at much higher levels. And, if the Viacyte collaboration on Diabetes is any way effective then clear the deck because it will change treatment forever. I am thinking long on this one but guess that in another 1 to 2 years you will not be able to buy this stock under $250-$300/share. Ten years down the road-who knows. I am long and holding even for the next bumps in the road---there are always some.
    Bullish
  • A
    American
    wow!
    Bullish
  • C
    Christopher
    Close over $126 today!
  • C
    Crab Cake
    Seems like the market is starting to realize that a $8B MC for a paradigm shifting technology is way too cheap.
  • S
    Simon
    Well done CRSP LONGS for not selling your shares cheaply to increase the demand. The price has no choice but to go up! Go CRSP!
    Bullish
  • V
    VirginiaLova
    $CRSP “effectively cured” sickle cell and beta thal per ceo on Jefferies call today. Unbelievable — also the cancer portfolio seems amazing, also mentioned diabetes treatment as being “version 2”. Finally, they see marketability of CTx001 “much sooner than anyone expected”. This is the future of medicine — ASH data will be absolutely wonderful data.
    Bullish
  • Y
    Yahoo Finance Insights
    CRISPR Therapeutics reached an all time high at 113.10
  • m
    mike
    The stocks a beast